Episode Details

In a stunning policy reversal, the U.S. Department of Commerce has lifted export restrictions on Anthropic's most advanced AI models just weeks after imposing them — and the whiplash is sending shockwaves through the industry. Anthropic is also making major moves with the launch of Claude Sonnet 5, a powerful but affordable agent-focused model, and Claude Science, a bold new research platform targeting pharma and biotech. Meanwhile, the United Nations dropped a sobering report warning that AI's rapid expansion could dramatically worsen global inequality — and not just because of access gaps. Australia is embroiled in a fierce copyright battle over a proposal that would let AI companies train on creative content in exchange for billions in infrastructure investment, drawing sharp backlash from the arts community. A new health survey of 2,500 Americans reveals a troubling link between frequent AI chatbot use and belief in debunked vaccine myths, raising urgent public health concerns. On the hardware front, an Nvidia rival just hit a $5 billion valuation with $1 billion in booked sales, and South Korean chipmakers are pouring over $550 billion into memory production to address a critical AI bottleneck. The semiconductor boom is real — and some chip stocks have already tripled in 2026.

Subscribe to Daily Inference: dailyinference.com
Love AI? Check out our other AI tools: 60sec.site and Artificial Intelligence Radio